Ionis Pharmaceuticals, Inc.

Halal Rating :
See Details
Last Price $37.32 Last updated:
Market Cap $6.12b
7D Change -0.8%
1 Year Change -0.8%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 21, 2024

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $117.68m $113.13m $49000.0 $4.15m 0.04% 3.67%
Dec. 31, 2023 $324.5m $152.74m - $4.56m 0.00% 2.98%
Sept. 30, 2023 $140.0m $146.3m - $4.2m 0.00% 2.87%

Company Impact

Help us evaluate Ionis Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates